Multi-Targeting CAR-T Cell Strategies to Overcome Immune Evasion in Lymphoid and Myeloid Malignancies

嵌合抗原受体 抗原 免疫系统 免疫疗法 医学 髓样 T细胞 免疫学 癌症研究
作者
Jessica Peter,Fabio Toppeta,Alexandre Trubert,Sophia Danhof,Michael Hudecek,Thomas Däullary
出处
期刊:Oncology Research and Treatment [Karger Publishers]
卷期号:48 (5): 1-15 被引量:7
标识
DOI:10.1159/000543806
摘要

Background: Chimeric antigen receptor (CAR)-T cell therapy has become a groundbreaking treatment for hematological malignancies, particularly lymphomas and multiple myeloma, with high remission rates in refractory and relapsed patients. However, most CAR-T therapies target a single antigen, such as CD19, which can result in immune evasion through antigen escape. This mechanism describes the downregulation or complete loss of the targeted antigen by the tumor cells, eventually leading to relapse. To address this issue, multi-targeting strategies like logic-gated CARs, adapter CARs, or combination therapies can increase the potency of CAR-T cells. These approaches aim to minimize immune evasion by targeting multiple antigens simultaneously, thereby increasing treatment durability. Additionally, advanced tools such as next-generation sequencing (NGS), direct stochastic optical reconstruction microscopy (dSTORM), or multiparametric flow cytometry are helping to identify novel tumor-specific targets and improve therapy designs. Summary: This review explores the current landscape of CAR-T cell therapies in lymphoid and myeloid malignancies, highlights ongoing clinical trials, and discusses the future of these innovative multi-targeting approaches to improve patient outcome. Key Messages: Antigen escape limits CAR-T cell therapy success, but multi-targeting strategies like logic gates and adapter CARs offer solutions. Optimizing antigen selection and CAR design, along with larger clinical trials, is essential for improving patient outcomes. Personalization using advanced technologies like CRISPR screening and single-cell RNA sequencing can enhance durability and effectiveness of treatments for heavily pretreated patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
图文不符完成签到,获得积分10
1秒前
1秒前
潇洒迎海发布了新的文献求助10
2秒前
田様的应助被renn采纳,获得30
2秒前
赘婿的应助被chillibb采纳,获得10
3秒前
上上完成签到 ,获得积分10
4秒前
小布发布了新的文献求助10
4秒前
Cynthia发布了新的文献求助10
5秒前
5秒前
清爽的疾发布了新的文献求助10
5秒前
Yang发布了新的文献求助10
5秒前
LeeNeaul发布了新的文献求助30
6秒前
steforeca发布了新的文献求助10
6秒前
6秒前
6秒前
6秒前
李悟尔完成签到,获得积分10
7秒前
7秒前
7秒前
8秒前
8秒前
zyq完成签到,获得积分10
9秒前
露露发布了新的文献求助10
9秒前
李渠发布了新的文献求助10
10秒前
10秒前
10秒前
易晨初晓发布了新的文献求助10
11秒前
某某完成签到,获得积分10
12秒前
My_magnum_opus的应助被zhikaiyici采纳,获得30
12秒前
12秒前
GingerF的应助被cndoupu采纳,获得60
12秒前
小马甲的应助被MM采纳,获得10
13秒前
xuxff完成签到,获得积分10
13秒前
tanjuan发布了新的文献求助10
13秒前
无情硬币发布了新的文献求助10
13秒前
fff发布了新的文献求助10
13秒前
BeHappy发布了新的文献求助10
14秒前
万能图书馆的应助被Yang采纳,获得10
14秒前
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184061
求助须知:如何正确求助?哪些是违规求助? 9573151
关于积分的说明 21829878
捐赠科研通 7781058
什么是DOI,文献DOI怎么找? 3434216
关于科研通互助平台的介绍 2558337
邀请新用户注册赠送积分活动 2480674